Radar › Companies › Life Sciences · Basque Country
Radar · Life Sciences in Basque Country

Best Life Sciences Companies in Basque Country, Spain

The 48 best Life Sciences companies in Basque Country, Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Oncomatryx.

48companies tracked
$61.5Mdisclosed funding
0unicorns
22have raised
FLIAR INTELLIGENCE · LIFE SCIENCES × BASQUE COUNTRY

Our analysis of 576 Life Sciences companies

$91.7b in tracked funding; 70% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.

576companies analysed
70%cloud-native stacks
2025funding peak (by rounds)
13unicorns
2016median founding year
115kcombined LinkedIn audience
42%of audience held by top 3
6companies hiring publicly (12 mo)

Ranked: Best Life Sciences companies in Basque Country

#CompanyDisclosed fundingLast roundStageFounderFoundedTech stackPatents & IP focusRecent signals
1Oncomatryx
Developer of antibody-drug conjugates targeting the tumor microenvironment
$26M4 mo agoSeries D—2009WordPressMySQLPHP+14——
2INNITIUS
Developer of a device for monitoring labor in pregnant women
$5M41 mo agoSeed—2007WordPressMySQLPHP+22—1 launch · 1 partnership
3Onena Medicines.
Developer of immunotherapies for the treatment of breast cancer
$4M33 mo agoSeries AMaider Zabala
Co-Founder
2019—5 patents
Patents concentrated in chemistry & materials
—
4VIVEbiotech
Developer and manufacturer of lentiviral vectors
$4M20 mo agoSeedGurutz Linazasoro
Founder & CEO
2015WordPressMySQLPHP+16——
5Histocell
Provider of products and services in cell therapy for regenerative medicine
$3M74 mo agoSeries A—2005Cart FunctionalityWordPressMySQL+19110 patents
Patents concentrated in health & consumer products
—
6Adaptam Therapeutics
Developer of antibody-based immunotherapies targeting the immunosuppressive myeloid tumor microenvironment
$3M9 mo agoSeedAsis Palazon
Founder & CEO/CSO
2023—4 patents
Patents concentrated in chemistry & materials
—
7Atlas Molecular Pharma
Develops proprietary drug discovery platform
$3M55 mo agoSeries AEnrique Castellon
CEO & President
2015—10 patents
Oral ciclopirox formulations and uroporphyrin-based therapies for prion diseases
—
8Gogoa
Developer of exoskeletons and robotic neuro-rehabilitation devices
$3M44 mo agoFunding Raised—2015Wix eCommerceWixSentry+14——
9microLIQUID
Specializes in microfluidics
$2M59 mo agoAcquiredBorja Barredo
Founder & CEO
2008—16 patents
Microfluidic sealing structures and monolithic normally‑closed valves for lab‑on‑a‑chip devices
—
10Irisbond
Developer of eye tracking solution to control a computer for disabled individuals
32Growth top 35%Talent bottom 49%Market bottom 43%Funding bottom 42%
All 7 signals ▾
Growthtop 35%
Talentbottom 49%
Marketbottom 43%
Fundingbottom 42%
Globalbottom 29%
Techbottom 26%
Newsbottom 22%
Growth: Fresh capital in last 24 mo
Talent: 1 named leader on record · 1 C-suite/founder profile curated
rank vs industry peers · Fliar Intelligence Index 32/100
$2M16 mo agoSeries AEduardo Torrecilla
Founder & CEO
2013WordPressMySQLPHP+12—1 job opening · 2 awards
11SOMAprobes
Provider of diagnostic kits for sensitive diagnosis of various diseases
$2M52 mo agoFunding RaisedMiguel Mulet
Co-Founder
2014—10 patents
Patents concentrated in computing, sensing & instrumentation
—
12Inmedical Therapeutics
Developer of medical devices to treat complications in therapeutic endoscopies
$871K30 mo agoSeedLuciano Conde
Founder
2021—4 patents
Patents concentrated in health & consumer products
—
13Innoprot
Provider of products and services in drug discovery
$628K76 mo agoFunding RaisedJorge Gamiz
Founder & CEO
2007Cart FunctionalityWooCommerceWordPress+25——
14Polimerbio
Developer of biodegradable polymers and medical devices using biocompatible materials
$334K78 mo agoSeedJose Sarasua
Co-Founder
2017WordPressPleskMySQL+199 patents
Patents concentrated in health & consumer products
—
15OSASEN
Developing and offering an amperometric enzymatic biosensors
$284K79 mo agoSeedAsier Albizu
CEO
2014———
16HAWK Biosystems
Developer of clinical assays for quantifying novel biomarkers
$123K50 mo agoSeedFernando Aguirre
CEO
2015WordPressMySQLPHP+28——
17Fesia Technology
Provider of functional electrical stimulation devices for the rehabilitation of individuals
$116K94 mo agoFunding RaisedHaritz Zabaleta
Co-Founder & CEO
2016———
18StemTek Therapeutics
Stem cell focused research services for drug development for cancer treatment
$108K111 mo agoDeadpooledAngel Garcia Martin
Co-Founder & CEO
2013—4 patents
3D culture techniques for generating cancer stem cell spheroids
—

Top 12 Life Sciences companies in Basque Country

#1
Series D · Derio, Basque Country · founded 2009 · 19 employees
$26.2Mraised
▾

Developer of antibody-drug conjugates targeting the tumor microenvironment. It develops novel therapies focused on modulating the tumor's microenvironment to overcome resistance to conventional cancer treatments. The company conducts clinical trials and is committed to bringing innovative solutions to cancer patients. Research efforts concentrate on understanding and targeting the tumor stroma, a new avenue for treating metastatic solid tumors. This approach involves orchestrated combinations of precision drugs targeting both the tumor and its surrounding microenvironment.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 6k LinkedIn followers — 5.5% of this cohort's audience
Funding rounds
  • Mar 2026Series D$67M
  • Jan 2025Series C$26.2M
  • Apr 2022Series B$16.2M
  • Nov 2019Series A$10M
Investors
Ekarpen, BBK, CDTI, Kutxa Fundazioa, Euskadi.eus
Tech stack
Apache Http ServerAutoptimizeComplianzCore-JsElementorGeneratepress
#2
Seed · San Sebastian, Basque Country · founded 2023
$3.5Mraised
▾

Developer of antibody-based immunotherapies targeting the immunosuppressive myeloid tumor microenvironment. It focuses on creating therapies directed to novel targets expressed in immunosuppressive myeloid cells. These therapies include antibody-drug conjugates and bispecific antibodies for oncology indications. The organization advances first-in-class antibody-based therapies.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 644 LinkedIn followers
Funding rounds
  • Oct 2025Seed$3.5M
Founders & team
Asis PalazonFounder & CEO/CSO
Investors
Criteria Bio Ventures
#3
Series A · San Sebastian, Basque Country · founded 2013 · 46 employees
$2.1Mraised
▾

Developer of eye tracking solution to control a computer for disabled individuals. The companys technology uses IR light beams which generate flashes in the users cornea, which is identified via a computer algorithm to operate the computer with the movement of the eyes. Its offerings include Irisbond eye-tracking camera, application to control computers and tablets with eyes, a grid style menu for access via eye-tracking.

Fliar Intelligence Index™ 32how this company ranks against its industry peers
Growth
top 35%
Talent
bottom 49%
Market
bottom 43%
Funding
bottom 42%
Global
bottom 29%
Tech
bottom 26%
Growth: Fresh capital in last 24 mo
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Market: 46 employees (top 44% of High Tech) · Top-5,000,000 web property
Audience (LinkedIn): 4k LinkedIn followers — 3.3% of this cohort's audience
Hiring (LinkedIn): 1 hiring post in 12 mo (public) · hiring: Ingeniera/o de Software para Sistemas Embebidos
Activity (LinkedIn): 1 partnerships · 2 awards (incl. Alamo Assistive Technology) announced in 12 mo
Funding rounds
  • Mar 2025Series A$4.9M
  • Nov 2023Seed$2.1M
Founders & team
Eduardo TorrecillaFounder & CEO
Investors
SGEIC, Spri, Fitalent, Bind 4.0, BBVA Momentum
Tech stack
Apache Http ServerCookiebotGoogle AnalyticsGoogle Font ApiGoogle WorkspaceHubspot
#4
Seed · San Sebastian, Basque Country · founded 2015 · 83 employees
$3.9Mraised
▾

Developer and manufacturer of lentiviral vectors. It offers manufacturing-related services such as analytical methods, stability studies, final products, cell banks, and regulatory support. It has developed Lentisoma which is a patented episomal non-integrative lentiviral vector.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 14k LinkedIn followers — 12.3% of this cohort's audience
Funding rounds
  • Dec 2024PE—
  • Sep 2019Seed$3.9M
Founders & team
Gurutz LinazasoroFounder & CEO
Investors
Inveready, Easo Ventures, Ampersand Capital
Tech stack
CloudflareComplianzDocusignGoogle AnalyticsGoogle Tag ManagerHttp/3
#5
Seed · Derio, Basque Country · founded 2007 · 22 employees
$5.4Mraised
▾

Developer of a device for monitoring labor in pregnant women. The Fine Birth is a portable device based on torsional waves for the diagnosis of conditions associated with a change in tissue consistency and differentiate between false pre-term labor and true pre-term labor.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 5k LinkedIn followers — 4.2% of this cohort's audience
Activity: 1 product launches · 1 partnerships (incl. GE HealthCare) announced in 12 mo
Funding rounds
  • Feb 2023Seed$1.9M
  • Dec 2022Grant (prize money)$4M
  • Oct 2022Grant (prize money)$3.7M
  • Apr 2019Grant (prize money)$55.8K
Investors
EIT Health, Europa, EIC Fund, Nara Capital, Clave, Knowledge Investors
Tech stack
WordpressMysqlPhpChart.JsWpbakeryContact Form 7
#6
Series A · San Sebastian, Basque Country · founded 2019 · 10 employees
$4.1Mraised
▾

Developer of immunotherapies for the treatment of breast cancer. The company is developing antibodies that block the activity of DSIP proteins to suppress dual-SMAD inhibition which controls adult stem cell immortality and progenitor cell maturation. The transferrable immortality sensor system platform is used for developing drugs.

Funding rounds
  • Oct 2023Series A$4.1M
Founders & team
Maider ZabalaCo-FounderNeethan LoboCo-Founder
Investors
AVANTECA, Zurcher Kantonalbank, Bind 4.0, BaseLaunch
#7
Funding Raised · Zumarraga, Basque Country · founded 2015 · 11 employees
$2.8Mraised
▾

Gogoa develops robotic devices for neuro-rehabilitation and neuro-mobility for people with disabilities or constricted movement capabilties. Their Hank exoskeleton is a 1.95 m tall lower body exoskeleton and can support a maximum body weight of 100 kgs. It has 6 powered joints at each of hips, knee and ankle. Hand of Hope offering is a robotic therapeutic device which facilitates muscle re-education by amplifying and rewarding a patient with desired motion. Gogoa was founded with a license from Cajal Institute in collaboration with the National Hospital for Paraplegics.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 4k LinkedIn followers — 3.1% of this cohort's audience
Funding rounds
  • Dec 2022Grant (prize money)$624.8K
  • Mar 2021Grant (prize money)$58.7K
  • Dec 2018Grant (prize money)$1.2M
  • Mar 2016Grant (prize money)$906.6K
Investors
Europa, EIC Fund, FABulous
Tech stack
BootstrapCdnjsCloudflareGoogle AnalyticsGoogle CloudGoogle Cloud Cdn
#8
Seed · Vitoria-Gasteiz, Basque Country · founded 2021
$871.5Kraised
▾

Developer of medical devices to treat complications in therapeutic endoscopies. The company is developing medical device product called Convergel to avoid complications in therapeutic endoscopies by accelerating the healing process of the wound.

Funding rounds
  • Jan 2024Seed$871.5K
Founders & team
Luciano CondeFounder
Investors
Spri, Viscofan
#9
Series A · Derio, Basque Country · founded 2015 · 6 employees
$3.4Mraised
▾

Atlas Molecular Pharma engages in developing drug discovery platform called CHASSYS. The technology is an integrated platform to develop new chemical entities and repurposed drugs. It is currently working on Congenital Erythropoietic Porphyria wherein the autosomal recessive deficiency in the uroporphyrinogen III synthase (UROIIIS) enzyme causes build up of porphyrins in high concentration. Additionally, the company is also working on Prion Disease: and Tyrosianemia along with other diseases.

Funding rounds
  • Jan 2022Series A$3.4M
  • Mar 2021Grant (prize money)$302.1K
  • 2016Seed—
Founders & team
Enrique CastellonCEO & President
Investors
Kereon Partners, Inveready, CDTI, Spri, CRB Inverbio, Europa
Tech stack
WordpressMysqlPhpDebianApache Http ServerHsts
#10
Acquired · Bilbao, Basque Country · founded 2008 · 60 employees
$2.3Mraised
▾

MicroLiquid engages in manufacturing microfluidic chip and microfluidic molds development and Microfluidic services. The company is ISO 13485-certified manufacturing processes and Class 10 and Class 10,000 cleanrooms.

Funding rounds
  • Sep 2021Grant (prize money)$358.8K
  • Jan 2019Grant (prize money)$173.8K
  • Jan 2018Grant (prize money)$448.4K
  • Nov 2017Grant (prize money)$948.3K
Founders & team
Borja BarredoFounder & CEO
Investors
Europa, Orza
#11
Series A · Derio, Basque Country · founded 2005 · 24 employees
$3.5Mraised
▾

HistoCell is a spin-off from the University of the Basque Country and engages in developing new technologies in regenerative medicine. The company uses Adult Mesenchymal Stem Cells (AMSCs) and bioactive materials (scaffolds) as their key technology and focuses n these therapeutic areas bone regeneration, advanced wound healing, inflammatory diseases, neurodegeneration, and ischemia or lung therapy. The product line of the company includes Wharton Gel complex (Cosmetic ingredient with regenerative property), medical device (Rexocare-wound dressing with antioxidant properties, Histogel (Natural product with tissue regeneration properties), Histobone (Engineered synthetic bone matrix of structured porous monetite (Calcium phosphate derivate) for osseous regeneration). Additionally, the company also offers services in the manufacturing of cell therapy products for therapeutic use.

LinkedIn Pulse recent public activity · Jul 2026
Audience: 8k LinkedIn followers — 7.2% of this cohort's audience
Hiring: 1 hiring post in 12 mo (public)
Funding rounds
  • Jun 2020Grant (prize money)$944.1K
  • Sep 2018Series A$3.5M
  • Jul 2017Grant (prize money)$58.8K
  • Feb 2017Grant (prize money)$53.8K
Investors
Cell Innovation Partners, Europa, EIC Fund, Orza
#12
Funding Raised · Gipuzkoa, Basque Country · founded 2014 · 10 employees
$1.8Mraised
▾

Provider of diagnostic kits for sensitive diagnosis of various diseases. The company leverages nucleases as diagnostic markers in the design of devices for in vitro diagnostics to detect various diseases such as sepsis, coronavirus, and cancer.

Funding rounds
  • Mar 2022Grant (prize money)$55.7K
  • Aug 2020Grant (prize money)$1.7M
Founders & team
Miguel MuletCo-FounderLuiza HernandezCo-Founder
Investors
EIC Fund, Europa
Tech stack
WordpressMysqlPhpVimeoDiviYoast Seo

Funding & investor landscape

$61.5Mtotal disclosed funding
19companies funded
48disclosed rounds
0rounds last 90 days
Most active investors
Europa14 rounds
EIC Fund9 rounds
Orza7 rounds
Bind 4.03 rounds
Spri3 rounds
CDTI2 rounds
CRB Inverbio2 rounds
Clave2 rounds
EIT Health2 rounds
European Union2 rounds

Notable founders

Asis Palazon
Founder & CEO/CSO · Adaptam Therapeutics
Eduardo Torrecilla
Founder & CEO · Irisbond
Gurutz Linazasoro
Founder & CEO · VIVEbiotech
Maider Zabala
Co-Founder · Onena Medicines.
Neethan Lobo
Co-Founder · Onena Medicines.
Luciano Conde
Founder · Inmedical Therapeutics
Enrique Castellon
CEO & President · Atlas Molecular Pharma
Borja Barredo
Founder & CEO · microLIQUID
Miguel Mulet
Co-Founder · SOMAprobes
Luiza Hernandez
Co-Founder · SOMAprobes
Jorge Gamiz
Founder & CEO · Innoprot
Jose Sarasua
Co-Founder · Polimerbio
Prism market signals · Spain · country-scoped Prism corpus, 1,393,736 docs

Market landscape — 10 sub-themes by coverage

Share of Life Sciences coverage by sub-theme.

Regulatory-risk over time rising

Funding & growth over time

funding rising · growth rising

RESEARCH SIGNALS · Spain

How research on Biotechnology is moving in Spain

A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 1,045 Spain-affiliated papers.

research sentiment over time
200820152026
enthusiastic · positive · guarded tone
Tone is overwhelmingly optimistic and softening — the enthusiastic (strongly-positive) share moved 44% → 40% across 2008–2026.
top research entities
  • Universidad Internacional De La Rioja128
  • Consejo Superior de Investigaciones Científicas40
  • Universidad Complutense de Madrid29
  • Universidade de Santiago de Compostela27
  • University of Córdoba26
leading researchers
Juan Moisés de la Serna · Pratyush Mishra · Vikas Kumar · Alicia Rodríguez · Ana Allende · Carlos Camacho · Diego Rubiales · Marta de Vicente
▲ Breakthroughs170 · 16%
▼ 23%→16% share
▼0.7× share momentum0 median citations85% since 2021mostly empirical
Breakthroughs are cooling (23%→16% of field), led by Population.
rising sub-themes (early→recent)
  • Population1→5
  • Flow cytometry1→5
  • Mutant1→4
  • DNA damage3→4
Newly emergingGene 0→9 · Genome 0→7 · Immune system 0→6
Landmark Defining the biomethane potential (BMP) of solid organic wastes and energy crops: a proposed protocol for batch assays · 1,939 cites
◆ Advancements359 · 34%
▲ 32%→35% share
▲1.1× share momentum0 median citations90% since 2021mostly empirical
Advancements are rising (32%→35% of field), led by Gene.
rising sub-themes (early→recent)
  • Gene1→15
  • Agriculture1→15
  • Health benefits2→9
  • Germplasm1→8
  • In vivo2→8
Newly emergingFermentation 0→21 · Biomass (ecology) 0→17 · Bacteria 0→12
Landmark Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice · 1,441 cites
▼ Concerns177 · 17%
▼ 23%→17% share
▼0.7× share momentum0 median citations87% since 2021mostly empirical
Concerns are cooling (23%→17% of field), led by Agriculture.
rising sub-themes (early→recent)
  • Agriculture2→15
  • Context (archaeology)1→13
  • Antibiotic resistance2→11
  • Antimicrobial1→9
  • Production (economics)1→9
Newly emergingSustainability 0→7 · Bacteria 0→5 · Disease 0→5
Landmark Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper · 1,450 cites
RESEARCH HOTSPOTS · Spain

Where biotechnology is researched across Spain

Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.

Madrid118 · +0.36
Hot · TranscriptomeAdvancing · MutantOpportunity · CellConcern · Antibiotic resistance
Barcelona52 · +0.47
Hot · GeneOpportunity · Agriculture
Valencia44 · +0.37
Hot · FermentationOpportunity · Cancer cell
Santiago de Compostela33 · +0.34
Opportunity · Life-cycle assessmentConcern · Animal production
Cerdanyola del Vallès28 · +0.42
Hot · Replication (statistics)Advancing · FermentationOpportunity · Medicinal plants
Granada26 · +0.39
Hot · BacteriaOpportunity · Recombinant DNA
Seville22 · +0.37
Opportunity · Population
Zaragoza21 · +0.36
Hot · In vitroAdvancing · GeneOpportunity · Genome
Pamplona13 · +0.28
Opportunity · Cell
Leioa9 · +0.27
Opportunity · Human health

Common questions

How many Life Sciences companies are there in Basque Country, Spain?
Radar tracks 48 indexable Life Sciences companies headquartered in Basque Country, Spain that meet our profile-completeness bar.
What is the total funding raised by Life Sciences companies in Basque Country, Spain?
The Life Sciences companies in Basque Country, Spain on this list have raised a combined $61.5M in disclosed equity funding across 19 funded companies.
Which is the highest-funded Life Sciences company in Basque Country, Spain?
Oncomatryx is the highest-funded Life Sciences company in Basque Country, Spain, with $26.2M in disclosed equity funding.
How many Life Sciences companies in Basque Country, Spain are funded?
19 of the 48 Life Sciences companies in Basque Country, Spain on this list have disclosed at least one equity funding round.
How many Life Sciences unicorns are there in Basque Country, Spain?
None of the Life Sciences companies in Basque Country, Spain on this list currently has a disclosed valuation of $1B or more.
Who are the top investors in Basque Country, Spain Life Sciences companies?
The most active investors in Basque Country, Spain Life Sciences companies on this list include Europa, EIC Fund, Orza, Bind 4.0, Spri.
Rohit KhannaTrends & Stories

Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.

Coming soon